|
2024 Journal Article Long COVID: Sufferers can take heartTindle, Robert (2024). Long COVID: Sufferers can take heart. Australian Journal of General Practice, 4 (4), 238-240. doi: 10.31128/AJGP-07-23-6896 |
|
2024 Journal Article Long COVID: Sufferers can take heartTindle, Robert (2024). Long COVID: Sufferers can take heart. Australian Journal of General Practice, 53 (4), 238-240. doi: 10.31128/AJGP-07-23-6896 |
|
2023 Journal Article Tumour-agnostic immunotherapy for rare and uncommon cancersTindle, Robert (2023). Tumour-agnostic immunotherapy for rare and uncommon cancers. Australian Journal of General Practice, 52 (12), 889-892. doi: 10.31128/AJGP-03-23-6772 |
|
2014 Journal Article The biology of an isolated population of the American Flamingo Phoenicopterus ruber in the Galapagos IslandsTindle, Robert W., Tupiza, Arnaldo, Blomberg, Simon P. and Tindle, L. Elizabeth (2014). The biology of an isolated population of the American Flamingo Phoenicopterus ruber in the Galapagos Islands. Galapagos Research, 68. |
|
2014 Journal Article Genetic and phenotypic evidence supports evolutionary divergence of the American flamingo (Phoenicopterus ruber) population in the Galápagos IslandsFrias-Soler, Roberto, Tindle, Elizabeth, Lopez, Georgina Espinosa, Blomberg, Simon, Studer-Thiersch, Adelheid, Wink, Michael and Tindle, Robert (2014). Genetic and phenotypic evidence supports evolutionary divergence of the American flamingo (Phoenicopterus ruber) population in the Galápagos Islands. Waterbirds, 37 (4), 349-361. doi: 10.1675/063.037.0402 |
|
2013 Journal Article Population dynamics of the Galapagos Flightless Cormorant Phalacrocorax harrisi in relation to sea temperatureTindle, Robert W., Tindle, Elizabeth, Vagenas, Dimitrios and Harris, Michael P. (2013). Population dynamics of the Galapagos Flightless Cormorant Phalacrocorax harrisi in relation to sea temperature. Marine Ornithology, 41 (2), 121-133. |
|
2010 Journal Article Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protectionHaigh, O., Kattenbelt, J., Cochrane, M., Thomson, S., Gould, A. and Tindle, R. (2010). Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection. Cancer Gene Therapy, 17 (10), 708-720. doi: 10.1038/cgt.2010.27 |
|
2010 Journal Article HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogensChen, Dekun, Edgtton, Kristy, Gould, Allan, Guo, Huayang, Mather, Michael, Haigh, Oscar, Cochrane, Melanie, Kattenbelt, Jacqueline, Thomson, Scott and Tindle, Robert (2010). HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens. Virology, 398 (1), 68-78. doi: 10.1016/j.virol.2009.11.042 |
|
2010 Journal Article Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.Herd, K. A., Nelson, M., Mahalingam, S. and Tindle, R. W. (2010). Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.. Journal of General Virology, 91 (5), 1302-1310. doi: 10.1099/vir.0.015396-0 |
|
2009 Journal Article Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responsesGu, Wenyi, Cochrane, Melanie, Leggatt, Graham, Payne, Elizabeth, Choyce, Allison, Zhou, Fang, Tindle, Robert and McMillan, Nigel (2009). Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses. Proceedings of the National Academy of Sciences of the United States of America, 106 (20), 8314-8319. doi: 10.1073/pnas.0812085106 |
|
2008 Journal Article Genetically modified hepatitis B surface antigen: A Powerful vaccine technology for the delivery of disease-associated foreign antigens.Thomson, S., Haigh, O., Gould, A. R. and Tindle, R. W. (2008). Genetically modified hepatitis B surface antigen: A Powerful vaccine technology for the delivery of disease-associated foreign antigens.. Current Drug Therapy, 3 (3), 226-234. doi: 10.2174/157488508785747844 |
|
2008 Journal Article Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory diseaseHerd, K. A., Nissen, M. D., Hopkins, P. M., Sloots, T. P. and Tindle, R. W. (2008). Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease. The Journal of Infectious Diseases, 197 (4), 584-592. doi: 10.1086/526536 |
|
2008 Journal Article Recombinant Hepatitis B surface antigen vaccines for the delivery of disease-related antigens.Tindle, Robert W., Oscar Haigh, Gould, Allan R. and Scott Thomson (2008). Recombinant Hepatitis B surface antigen vaccines for the delivery of disease-related antigens.. Current Trends in Immunology, 9, 51-60. |
|
2007 Journal Article Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg)vaccine enhance CTL responses, but not tumor protectionHaigh, Oscar, Guo, Huayang, Edgtton, Kristy, Mather, Michael, Herd, Karen A. and Tindle, Robert W. (2007). Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg)vaccine enhance CTL responses, but not tumor protection. Virology, 368 (2), 363-375. doi: 10.1016/j.virol.2007.06.041 |
|
2007 Journal Article Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccineHerd, Karen A., Wiethe, Carsten and Tindle, Robert W. (2007). Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine. Vaccine, 25 (28), 5209-5219. doi: 10.1016/j.vaccine.2007.04.083 |
|
2006 Journal Article Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopesWoo, Wai-Ping, Doan, Tracy, Herd, Karen A., Netter, Hans-Jurgen and Tindle, Robert W. (2006). Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes. Journal Of Virology, 80 (8), 3975-3984. doi: 10.1128/JVI.80.8.3975-3984.2006 |
|
2006 Journal Article Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in miceHerd, Karen A., Mahalingam, Suresh, Mackay, Ian M., Nissen, Michael, Sloots, Theo P. and Tindle, Robert W. (2006). Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. Journal of Virology, 80 (4), 2034-2044. doi: 10.1128/JVI.80.4.2034-2044.2006 |
|
2005 Journal Article A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumourDoan, T., Herd, K., Ramshaw, I., Thomson, S. and Tindle, R. W. (2005). A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour. Cancer Immunology Immunotherapy, 54 (2), 157-171. doi: 10.1007/s00262-004-0544-6 |
|
2004 Journal Article Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumourHerd, Karen A., Harvey, Tracey, Khromykh, Alexander A. and Tindle, Robert W. (2004). Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour. Virology, 319 (2), 237-248. doi: 10.1016/j.virol.2003.10.032 |
|
2003 Journal Article Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B(RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigenWiethe, C., Dittmar, K., Doan, T., Lindenmaier, W. and Tindle, R. (2003). Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B(RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. Journal of Immunology, 171 (8), 4121-4130. doi: 10.4049/jimmunol.171.8.4121 |
